A novel liquid chromatography-tandem mass spectrometry method was validated for identification and quantification of @entity3175 , @entity12029 and metabolites in @entity7978 ( @entity7978 ), a complex matrix used to provide the nutrients required for bacterial growth. The method was designed for subsequent use in the investigation of gastrointestinal bacteria as a potential source of postmortem alteration of drugs of abuse and respective metabolite concentrations. A literature review yielded no experimental means or model for the extraction and analysis of samples from @entity7978 or similar bacterial medium. Development and validation of a new experimental method were therefore critical. In future work, this method could be adapted and extended to similar organic compounds of interest. The calibration curves extended from 0.100 to 500 ng/mL. Analyte recoveries ranged from 95 to 119% and matrix effects from 97 to 119%. Bias was  <=  17.6%, within-run precision  <=12.2%, and between-run precision  <=11.7% across all concentration levels. The limits of detection and quantitation ranged from 0.100 to 1 ng/mL. Dilution integrity was maintained for 1:2 and 1:5 dilutions. Analytes were stable through two freeze-thaw cycles and processed samples for 48 h. Method robustness was evaluated by changes in buffer composition and column temperature as well as samples prepared by an alternate analyst.

Simultaneous Quantification of @entity3175 , XXXX and Metabolites in Reinforced Clostridial Medium by Liquid Chromatography-Tandem Mass Spectrometry.

@entity3175 :: ('MESH:D003975', 'Chemical') :: ['diazepam'] @entity12029 :: ('MESH:D005445', 'Chemical') :: ['flunitrazepam'] @entity7978 :: ('MESH:C536038', 'Disease') :: ['reinforced clostridial medium', 'RCM']
@entity12029 :: (MESH:D005445,Chemical) :: ['Flunitrazepam']
